Ascendis Pharma A/S (ASND) has the following price history information. Looking back at ASND historical stock prices for the last five trading days, on April 29, 2024, ASND opened at $136.48, traded as high as $142.43 and as low as $136.48, and closed at $140.15. Trading volume was a total of 269.00K shares. On April 30, 2024, ASND opened at $139.88, traded as high as $141.47 and as low as $137.00, and closed at $138.44. Trading volume was a total of 260.50K shares. On May 01, 2024, ASND opened at $137.81, traded as high as $142.55 and as low as $136.00, and closed at $141.01. Trading volume was a total of 411.20K shares. On May 02, 2024, ASND opened at $141.79, traded as high as $143.99 and as low as $139.26, and closed at $141.10. Trading volume was a total of 318.50K shares. On May 03, 2024, ASND opened at $141.96, traded as high as $142.36 and as low as $135.16, and closed at $137.20. Trading volume was a total of 511.40K shares.

ASND Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ascendis Pharma A/S shares, starting with a $10,000 purchase of ASND, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	01/29/2015
End date:	05/03/2024
Start price/share:	$20.00
End price/share:	$137.20
Dividends collected/share:	$0.00
Total return:	586.00%
Average Annual Total Return:	23.11%
Starting investment:	$10,000.00
Ending investment:	$68,610.15
Years:	9.26

ASND Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$136.48	$142.43	$136.48	$140.15	269.00K
04/30/2024	$139.88	$141.47	$137.00	$138.44	260.50K
05/01/2024	$137.81	$142.55	$136.00	$141.01	411.20K
05/02/2024	$141.79	$143.99	$139.26	$141.10	318.50K
05/03/2024	$141.96	$142.36	$135.16	$137.20	511.40K

About Ascendis Pharma A/S

Ascendis Pharma is a biopharmaceutical company. Co.'s primary investigational product candidate, TransCon Growth Hormone, is in development as a once-weekly prodrug of recombinant human growth hormone as a potential treatment for pediatric growth hormone deficiency. Co. is also using its TransCon technologies to develop other product candidates to address rare endocrine diseases. These product candidates include TransCon Parathyroid Hormone as a potential treatment for adult hypoparathyroidism and TransCon C-Type Natriuretic Peptide as a potential therapeutic option for achondroplasia, the most common form of dwarfism.

ASND Historical Closing Prices
Date	Close
04/29/2024	$140.15
04/30/2024	$138.44
05/01/2024	$141.01
05/02/2024	$141.10
05/03/2024	$137.20

ASND Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.